Parabilis Medicines, Inc. (PBLS)
$39.29+0.08%Close
BUY
Key stats
Short interest · FINRA settlement 2026-08-14
- Market cap
- $129M
- Avg volume
- 648.7K
- Beta
- 0.00
- P/E (TTM)
- -1.06
- Short % float
- 173.23%
- Days to cover
- 15.7
- SI change
- +2.7%
- 1W
- -0.73%
- 1M
- +23.63%
- YTD
- +24.34%
- vs SPY 1W
- -1.85%
- vs SPY 1M
- +17.92%
- vs SPY YTD
- +11.46%
Sector peers
Same-sector names ranked by LOPJLB quality proximity · Healthcare
- INOBUYInovio Pharmaceuticals, Inc.RECOVERYQ 3$1.26-3.08%
- ANEBBUYAnebulo Pharmaceuticals, Inc.CRISISQ -4$0.33+0.00%
- NTRBBUYNutriband Inc.RECOVERYQ 12$4.62+2.67%
- ALGSBUYAligos Therapeutics, Inc.RECOVERYQ -21$7.07-5.86%
- ALMSSELLAlumis Inc. Common StockCRISISQ 32$23.21-1.74%
- PROFSELLProfound Medical Corp.RECOVERYQ 13$6.96-2.11%
- PRQRBUYProQR Therapeutics N.V.RECOVERYQ 6$2.32-1.28%
- OGENSELLOragenics, Inc.RECOVERYQ -10$0.53+0.00%
- POMBUYPOMDOCTOR LtdCRISISQ -36$0.95+0.00%
- CGONBUYCG Oncology, Inc. Common stockBULLQ 32$79.01+0.75%
- HCATSELLHealth Catalyst, Inc.CRISISQ -17$1.59+0.00%
- DTILBUYPrecision BioSciences, Inc.RECOVERYQ -21$8.40-1.06%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
FUNDAMENTALS
[SCORES & PROFILE]
- FUND
- 5
- VALUE
- 6
- GROWTH
- 19
- GARP
- 5
- TYPE
- Balanced
Composite of Value · Growth · GARP
ROIC-9.1%
REV YoY-
ROE-15.1%
EPS YoY-
ROA-8.3%
GROSS100
OP-66445
NET-66067
[VALUATION]
P/E TTM-1.06
P/E FWD-
SECTOR PE22.44
INDUSTRY PE17.24
P/B1.08
P/FCF-
EV/EBITDA-36.85
EV/EBIT-
PEG-
FCF YIELD-
RISK
INT COV-
D/E4.53
ALTMAN Z-
CURR RATIO17.91
ND/EBITDA-
BETA0.00
